Amyloid-PET: a new tool for diagnosing IBM?

Press/Media: Expert comment

Release date: 2/5/2019


Inclusion body myositis (IBM) and polymyositis can normally be distinguished on the basis of clinical features. However, patients with an atypical disease presentation, particularly those with early-stage disease, can be challenging to diagnose. Can imaging with amyloid-PET help distinguish these two diseases?

Refers to Lilleker, J. B. et al. [18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis. Ann. Rheum. Dis. 78, 657–662 (2019).

Media coverage

TitleAmyloid-PET: a new tool for diagnosing IBM?
Degree of recognitionInternational
Media name/outletNat Rev Rheumatol.
Media typeWeb
Producer/AuthorNature Research
PersonsJames Lilleker

Related information